Goldvaser, H.; Khutsurauli, S.; Buchinger, M.; Safonov, A.; Grinshpun, A.
Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. Cancers 2026, 18, 2077.
https://doi.org/10.3390/cancers18132077
AMA Style
Goldvaser H, Khutsurauli S, Buchinger M, Safonov A, Grinshpun A.
Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. Cancers. 2026; 18(13):2077.
https://doi.org/10.3390/cancers18132077
Chicago/Turabian Style
Goldvaser, Hadar, Salome Khutsurauli, Michele Buchinger, Anton Safonov, and Albert Grinshpun.
2026. "Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis" Cancers 18, no. 13: 2077.
https://doi.org/10.3390/cancers18132077
APA Style
Goldvaser, H., Khutsurauli, S., Buchinger, M., Safonov, A., & Grinshpun, A.
(2026). Oral Estrogen Receptor Degraders Compared to Standard Endocrine Therapy in Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Metastatic Breast Cancer: A Systematic Review and Meta-Analysis. Cancers, 18(13), 2077.
https://doi.org/10.3390/cancers18132077